CAS number：744198-19-4 molecular formula：C21H22BrN3O5
KCC009, a transglutaminase 2 (TG2) inhibitor, induces p53-independent radiosensitization. In Vitro The inhibition rates were 15.33±1.46 (%) for H1299/WT-p53 cells, and 14.31±1.90 (%) for H1299/M175H-p53 cells when cells were treated with KCC009 at concentration of 3.91 uM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid
| Chinese alias | - | ||
| English alias | KCC 009 | Benzyl (s)-1-((3-bromo-4,5-dihydroisoxazol-5-yl)methylamino)-3-(4-hydroxyphenyl)-1-oxopropan-2-ylcarbamate | DTXSID40349369 | MS-28833 | HY-123290 | AC1LD8ZC | Carbamic acid, [(1S)-2-[[(3-bromo-4,5-dihydro-5-isoxazolyl)methyl]amino]-1-[(4-hydrox | ||
| CAS number | 744198-19-4 | molecular formula | C21H22BrN3O5 |
| molecular weight | 476.32 g/mol | Exact mass | ≥98% |
| PSA | 109.000 Ų | logp | 3.200 |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
